异端邪说2 发表于 2025-3-28 15:17:41
http://reply.papertrans.cn/23/2219/221843/221843_41.png描绘 发表于 2025-3-28 20:35:25
http://reply.papertrans.cn/23/2219/221843/221843_42.pngTransfusion 发表于 2025-3-29 00:35:14
http://reply.papertrans.cn/23/2219/221843/221843_43.png平息 发表于 2025-3-29 05:09:20
Book 1985neric cardiac valvular surgery meeting, focusing primarily on valve replacement rather than valve repair . Thus, these proceed ings contain a wide spectrum of topics, including a keynote presentation on criteria for selection of cardiac valve substitutes in 1984, complications of cardiac valve roxidize 发表于 2025-3-29 08:24:17
a more generic cardiac valvular surgery meeting, focusing primarily on valve replacement rather than valve repair . Thus, these proceed ings contain a wide spectrum of topics, including a keynote presentation on criteria for selection of cardiac valve substitutes in 1984, complications of cardiac valve r978-1-4612-9629-4978-1-4613-2601-4CRUMB 发表于 2025-3-29 14:47:14
http://reply.papertrans.cn/23/2219/221843/221843_46.pngexpound 发表于 2025-3-29 16:36:00
st three symposia on this topic were held primarily for designated investigators involved in clinical trials of the ST. JUDE MEDICAL valve. The last meeting, chaired by Michael E. DeBakey, M.D., was held in November 1982 , immediately before the valve was released for general clinical use in theGREEN 发表于 2025-3-29 21:27:09
http://reply.papertrans.cn/23/2219/221843/221843_48.pngharbinger 发表于 2025-3-30 01:09:55
Vittorio Degiorgio,Ilaria Cristianitely, bioprosthesis must still be considered a temporary valve substitute. Due to its limited durability, one must consider the risks of future reoperation for valve replacement when weighing the potential benefits of a bioprosthesis. This chapter assesses the risks of valve reoperation and its effect on subsequent longevity.Nausea 发表于 2025-3-30 05:26:08
http://reply.papertrans.cn/23/2219/221843/221843_50.png